All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1. [electronic resource]
Producer: 19970623Description: 277-86 p. digitalISSN:- 0014-4827
- Adenocarcinoma -- pathology
- Animals
- Antineoplastic Agents -- pharmacology
- Cattle
- Cell Division -- drug effects
- DNA Replication -- drug effects
- DNA, Neoplasm -- biosynthesis
- Estradiol -- pharmacology
- Female
- Fetal Blood -- physiology
- G1 Phase -- drug effects
- Growth Inhibitors -- pharmacology
- Humans
- Insulin -- pharmacology
- Insulin-Like Growth Factor I -- pharmacology
- Neoplasm Proteins -- biosynthesis
- Ovarian Neoplasms -- pathology
- RNA, Messenger -- biosynthesis
- RNA, Neoplasm -- biosynthesis
- Signal Transduction -- drug effects
- Transforming Growth Factor beta -- biosynthesis
- Tretinoin -- pharmacology
- Tumor Cells, Cultured -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.